MD1612G2 - Method of the chronical pyelonephritis treatment during pregnancy - Google Patents

Method of the chronical pyelonephritis treatment during pregnancy

Info

Publication number
MD1612G2
MD1612G2 MDA20000104A MD20000104A MD1612G2 MD 1612 G2 MD1612 G2 MD 1612G2 MD A20000104 A MDA20000104 A MD A20000104A MD 20000104 A MD20000104 A MD 20000104A MD 1612 G2 MD1612 G2 MD 1612G2
Authority
MD
Moldova
Prior art keywords
chronical
pyelonephritis
day
during
days
Prior art date
Application number
MDA20000104A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD1612F1 (en
Inventor
Наталия ЗАРБАЙЛОВ
Людмила ЕЦКО
Григоре БИВОЛ
Виктор КАНЦЕР
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDA20000104A priority Critical patent/MD1612G2/en
Publication of MD1612F1 publication Critical patent/MD1612F1/en
Publication of MD1612G2 publication Critical patent/MD1612G2/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention refers to medicine, namely, to the internal medicine and can be applied for treatment of chronical pyelonephritis during the pregnancy.Summary of the invention consists in radiation of blood in the cubital vein zone with helio-neon laser rays daily during 7…10 days transcutaneous and in kindneys projection zone with IR-rays in a day in the pulsing regime.Additionally, during 28...35 days it is administered a metabolic-adaptogenic remedy on the basis of Spirulina platensis 0,5…1,0 g 2…3 times a day and a herb decoction possessing diuretic and antiseptic effect, 100…200 ml a day in two steps.
MDA20000104A 2000-06-20 2000-06-20 Method of the chronical pyelonephritis treatment during pregnancy MD1612G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20000104A MD1612G2 (en) 2000-06-20 2000-06-20 Method of the chronical pyelonephritis treatment during pregnancy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20000104A MD1612G2 (en) 2000-06-20 2000-06-20 Method of the chronical pyelonephritis treatment during pregnancy

Publications (2)

Publication Number Publication Date
MD1612F1 MD1612F1 (en) 2001-02-28
MD1612G2 true MD1612G2 (en) 2001-08-31

Family

ID=19739609

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20000104A MD1612G2 (en) 2000-06-20 2000-06-20 Method of the chronical pyelonephritis treatment during pregnancy

Country Status (1)

Country Link
MD (1) MD1612G2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1348G2 (en) * 1998-12-24 2000-05-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for treatment of aggravated chronic pyelonephritis in the gestation period

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1348G2 (en) * 1998-12-24 2000-05-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for treatment of aggravated chronic pyelonephritis in the gestation period

Also Published As

Publication number Publication date
MD1612F1 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
ES2040232T3 (en) MEDICINAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING A SINGLE DOSE OF 10 TO 240 MG OF DIHIDROPIRIDINA.
HUT63564A (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
EP0637239A4 (en) Method of promoting nitrogen retention in humans.
PT97552A (en) METHOD FOR PREPARING FORMS OF DOSAGE FOR THE ADMINISTRATION OF DRUGS FOR THE TREATMENT OF PARKISON'S DISEASE
HUP0102489A2 (en) Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
TR200001891T2 (en) ASPB28- Human insulin and its use.
NO171145C (en) PROCEDURE FOR PREPARING A FAT EMULSION WITH A HYDROPHOBIC MEDICINE
PT97785A (en) METHOD FOR IMPROVING TREATMENT USING, FOR EXAMPLE, DOXAZOSINE
McMahon Disulfiram-like reaction to a cephalosporin
MD1612G2 (en) Method of the chronical pyelonephritis treatment during pregnancy
MD1611G2 (en) Antibacterial and antifungal remedy
NO914118D0 (en) Means for the care of nails, skin and hair
DE69531166D1 (en) MEDICINAL PRODUCT TO RELEASE THE SIDE EFFECTS CAUSED BY IMMUNE SUPPRESSIVES
EA199800770A1 (en) DRUGS FOR THERAPEUTIC TREATMENT OF VIRAL HEPATITIS
SE9101341D0 (en) NEW MEDICINAL USE
KR890015746A (en) How to treat AIDS cachexia with megestrol acetate
EP0397211A3 (en) Percutaneous administration of 3'-azide-3'-deoxythymidine
Sharpe Xylene for removal of wax
ES2038578T1 (en) USE OF HUMAN G IMMUNOGLOBULINS, OR OF THESE FC FRAGMENTS, AS A PREPARATORY MEDICINE FOR THE ADMINISTRATION OF MONOCLONAL ANTIBODIES TO MEN.
MD1469G2 (en) Method of treatment of the burn shock
MD1393G2 (en) Method of prophylaxis of the pielonephritis chronic recidivations during pregnancy
RU94042546A (en) Method of neurosublingual coding of alcohol dependence
Netravalkar Medicines in ancient period
RU94000695A (en) Agent showing antiallergic action
DE3811177A1 (en) Use of alpha -aminoisocaproic acid (leucine) as active substance for controlling the HIV disease AIDS